View Older Stories View More Recent Stories

Apr 26, 2021 08:45AM Nevro Introduces HFX, New Comprehensive Brand Identity Combining Nevro's Innovative Technologies, Advanced Therapies and End-to-End Patient Support
Apr 19, 2021 07:00AM Nevro Appoints Jon R. Shear as Vice President, Corporate Development
Apr 13, 2021 07:00AM Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
Apr 7, 2021 07:00AM Nevro to Report First Quarter 2021 Financial Results
Apr 5, 2021 11:05AM Nevro (NVRO) Announces Publication Of Landmark SENZA-PDN Clinical Trial Results In JAMA Neurology
Apr 5, 2021 11:04AM Nevro Announces Publication Of Landmark SENZA-PDN Clinical Trial Results In JAMA Neurology
Feb 24, 2021 04:05PM Nevro Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 1, 2021 07:00AM Nevro to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Feb 1, 2021 07:00AM Nevro to Present at 10th Annual SVB Leerink Global Healthcare Conference
Jan 27, 2021 07:00AM Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results
Jan 19, 2021 07:00AM Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® Therapy
Jan 14, 2021 07:00AM Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting
Jan 11, 2021 07:08AM Nevro (NVRO) Announces Preliminary Q4 Revenue
Jan 11, 2021 07:00AM Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2020 Revenue
Dec 28, 2020 04:11PM Nevro (NVRO) Submits FDA Pre-Market Approval Supplement for HF10 Therapy
Dec 28, 2020 04:08PM Nevro Announces FDA Submission for HF10® Therapy in Patients with Painful Diabetic Neuropathy
Dec 22, 2020 04:05PM Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference
Dec 15, 2020 04:05PM Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021
Dec 14, 2020 06:54PM Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California
Dec 14, 2020 04:30PM Nevro Announces Agreement to Conclude Its Patent Lawsuit in the Northern District of California Against Boston Scientific
Nov 30, 2020 07:00AM Nevro Appoints Julie D. Dewey as Vice President, Investor Relations and Corporate Communications
Nov 24, 2020 07:00AM ­Nevro to Participate in Citi Bank Head Shoulders Knees and Toes Conference Call Series on November 30th
Nov 17, 2020 04:02PM Nevro Announces Abstract Presentations for PDN and NSRBP Trials Have Been Accepted for the Late Breaking Trials Plenary Session at NANS 2021 Conference
Nov 5, 2020 04:02PM Nevro Announces Third Quarter 2020 Financial Results
Oct 22, 2020 04:05PM Nevro to Report Third Quarter 2020 Financial Results
Sep 14, 2020 07:06AM Nevro (NVRO) Initiates Plan for Manufacturing Operations in Costa Rica to Support Future Growth
Sep 14, 2020 07:00AM Nevro Initiates Plan for Manufacturing Operations in Costa Rica to Support Future Growth
Sep 1, 2020 07:00AM Nevro to Present at Upcoming Conferences
Aug 7, 2020 07:00AM Nevro to Present at Canaccord Genuity 40th Annual Virtual Growth Conference
Aug 5, 2020 04:10PM Nevro Announces Second Quarter 2020 Financial Results
Jul 20, 2020 07:00AM ­Nevro to Report Second Quarter 2020 Financial Results
Jun 4, 2020 07:09AM Nevro (NVRO) Announces Roderick MacLeod as CFO
Jun 4, 2020 07:00AM Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
May 14, 2020 07:00AM Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain
May 5, 2020 04:10PM Nevro Reports First Quarter 2020 Financial Results
May 4, 2020 07:00AM Nevro To Participate in Upcoming May Conferences
Apr 21, 2020 07:00AM Nevro to Report First Quarter 2020 Financial Results
Apr 9, 2020 12:42PM Nevro Announces Federal Circuit Rules in its Favor and Upholds the Validity of Nevro's Patent Claims In Its Litigation Against Boston Scientific
Apr 3, 2020 04:44PM Nevro Announces the Full Exercise of the Underwriter's Option to Purchase Additional Common Stock and the Underwriter's Over-allotment Option to Purchase Additional Convertible Senior Notes
Apr 2, 2020 08:09AM Nevro (NVRO) Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Apr 2, 2020 08:00AM Nevro Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Apr 1, 2020 04:45PM Nevro (NVRO) Announces Proposed 1.625M Shares Common Offering
Apr 1, 2020 04:40PM Nevro Announces Proposed Public Offering of Common Stock and Convertible Senior Notes
Apr 1, 2020 04:09PM Nevro (NVRO) withdraws its previously announced annual guidance for 2020
Apr 1, 2020 04:07PM Nevro Provides First Quarter and FY2020 Update
Feb 28, 2020 08:47AM Nevro (NVRO) Files Lawsuit for Patent Infringement Against Nalu Medical in U.S.
Feb 28, 2020 08:45AM Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction
Feb 28, 2020 08:45AM Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S.
Feb 25, 2020 04:10PM Nevro Reports Fourth Quarter and Full Year 2019 Financial Results
Feb 3, 2020 07:00AM ­Nevro to Report Fourth Quarter and Full Year 2019 Financial Results
View More Recent Stories View Older Stories